Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Jornal de Pediatria

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPEDS.2007.03.002PMID 17586196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report

  2007cited by this paper
• Risk of Recurrent Childhood Arterial Ischemic Stroke in a Population-Based Cohort: The Importance of Cerebrovascular Imaging

  2007cited by this paper
• Sweat‐testing in preterm and full‐term infants less than 6 weeks of age

  2005cited by this paper
• Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.

  2005influential reference
• Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.

  2005cited by this paper
• Sweat testing infants detected by cystic fibrosis newborn screening.

  2005cited by this paper
• Diagnosis of cystic fibrosis after newborn screening: The Australasian experience—twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory group

  2005cited by this paper
• Sweat testing in newborns positive to neonatal screening for cystic fibrosis

  2004cited by this paper
• Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule.

  2003cited by this paper
• Assessment of sweat-testing practices for the diagnosis of cystic fibrosis.

  2001cited by this paper
• The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

  1998cited by this paper
• Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

  1996cited by this paper
• Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.

  1994cited by this paper
• Stability of chloride in sweat testing

  1993cited by this paper
• Misdiagnosis of Cystic Fibrosis

  1987cited by this paper
• Laboratory confirmation of the diagnosis of cystic fibrosis.

  1976cited by this paper
• Sweat tests in the newborn period.

  1973cited by this paper
• Micropuncture studies of the sweat formation in cystic fibrosis patients.

  1969cited by this paper

• Smart microfluidics-powered home-based diagnostics for one-health: From technologies to applications

  2026cites this paper
• Relationship between sweat chloride and pulmonary function in healthy young adults - a single-center, pilot study.

  2025cites this paper
• Efficient sweat induction and pilocarpine delivery on the forearm but not the palm using coated microneedles in humans

  2025cites this paper
• Research progress of wearable electrochemical biosensors based on metal–organic frameworks (MOFs) for sweat detection

  2025cites this paper
• Hydrogel-based sweat chloride sensor with high sensitivity and low hysteresis.

  2025cites this paper
• Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study

  2025cites this paper
• Sweat testing and cystic fibrosis – Test performance before and after a quality improvement project in a South African tertiary hospital laboratory

  2025cites this paper
• Efficacy of elexacaftor/tezacaftor/ivacaftor in non-cystic fibrosis bronchiectasis patients with a single pathogenic CFTR mutation: a retrospective cohort analysis

  2025cites this paper
• Neonatology Providers Need Education About Cystic Fibrosis Newborn Screening Algorithms

  2025cites this paper
• Innovative Niosome- Based Dermal Drug Delivery System: A Potential Advancement in Transdermal Therapeutics

  2025cites this paper
• TAS2R38 genotype and CRS severity in children with cystic fibrosis

  2025cites this paper
• Wireless Colorimetric Multi-Biomarker Sensing to Enable Critical Neonatal Monitoring

  2025influential citation
• Taste and Smell Disorders in Children and Young Adults With Cystic Fibrosis and Primary Ciliary Dyskinesia—A Prospective Comparative Study

  2025cites this paper
• Cystic Fibrosis Newborn Screening.

  2025cites this paper
• Improved Clinical Outcomes With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease: Real‐World Evidence From an Italian Single‐Center Study

  2025cites this paper
• Next-Generation Sequencing for Cystic Fibrosis: Florida Newborn Screening Experience

  2025cites this paper
• Connexin 30 (GJB6) deletion as a cause of a false positive sweat test result

  2025cites this paper
• Evaluating CRMS/CFSPID phenotypes and outcomes: A retrospective study from a large UK cystic fibrosis centre

  2024cites this paper
• Central auditory system assessment in children and adolescents with cystic fibrosis: electrophysiology and central auditory processing

  2024cites this paper
• Recent advances in biomarkers detection of various diseases by biosensors derived from optical chromogenic polymeric transducers: A review

  2024cites this paper
• Rate and predictors of insufficient sweat volume in very young infants after pilocarpine gel iontophoresis: prospective, population-based study

  2024cites this paper
• Diving into Sweat: Advances, Challenges, and Future Directions in Wearable Sweat Sensing.

  2024cites this paper
• Pretreatment of microneedles enhances passive transdermal administration of pilocarpine and pilocarpine-induced sweat production in humans.

  2024cites this paper
• Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis

  2024cites this paper
• Recent Advances in Self‐Powered Electrochemical Biosensors for Early Diagnosis of Diseases

  2024cites this paper
• Advanced fluorescent probes, portable electrochemical and colorimetric sensors for detection of chloride ions in bodily fluids, foods and waters

  2024cites this paper
• CFTrack: Advanced Diagnostic, Monitoring, and Tracking Device for Cystic Fibrosis Care.

  2024cites this paper
• Fluorescence sensing of chloride ions in water based on wavelength shifts of hexane-dispersed CsPbBr3@silicone

  2024cites this paper
• Diagnosing Cystic Fibrosis in the 21st Century—A Complex and Challenging Task

  2024influential citation
• Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team.

  2024cites this paper
• Development of a reagent-free electrochemical disposable sensor strip for the quantification of sweat chloride

  2024cites this paper
• Diagnosis and treatment of cystic fibrosis in India: What is at stake for developing countries?

  2024cites this paper
• A self-powered wireless sweat-analysis patch for real-time monitoring physiological status

  2024cites this paper
• Electrochemical Sweat Sensors

  2023cites this paper
• Variability of the sweat test in children with Cystic Fibrosis previously CRMS/CFSPID: A retrospective monocenter experience.

  2023cites this paper
• Wearable sweat biosensors on textiles for health monitoring

  2023cites this paper
• Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

  2023cites this paper
• Cesium lead bromide perovskite nanocrystals for the visual detection of chloride ions: A review

  2023cites this paper
• Variation in human functional eccrine gland density and its implications for the evolution of human sweating.

  2023cites this paper
• Fibers/Textiles-Based Flexible Sweat Sensors: A Review

  2023cites this paper
• Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS/CFSPID: A monocentric prospective experience

  2023cites this paper
• Multifunctional Wearable System for Mapping Body Temperature and Analyzing Sweat.

  2023cites this paper
• Electrochemical sensing of heavy metals in biological media: A review

  2023cites this paper
• Sweat conductivity for diagnosing cystic fibrosis after positive newborn screening: prospective, diagnostic test accuracy study

  2023cites this paper
• Imidazole-based fluorophores: Synthesis and applications

  2023cites this paper
• Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening

  2023cites this paper
• Sweat induction using Pilocarpine microneedle patches for sweat testing in healthy adults.

  2023cites this paper
• Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis

  2023cites this paper
• Reexamining the Minimum Sweat Rate Requirement for Sweat Chloride Testing.

  2023cites this paper
• Cystic Fibrosis.

  2023cites this paper
• Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age

  2023cites this paper
• Rapid detection of urine chloride enabled by ion exchange in hydrophilic lead halide perovskite nanocrystals.

  2023cites this paper
• CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons

  2022cites this paper
• Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules

  2022cites this paper
• Novel Approach to Track the Lifecycle of Inflammation from Chemokine Expression to Inflammatory Proteins in Sweat Using Electrochemical Biosensor

  2022cites this paper
• Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype.

  2022cites this paper
• Effect of Triple Combination CFTR Modulator Therapy on Sleep in Adult Patients with Cystic Fibrosis

  2022cites this paper
• Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification

  2022cites this paper
• Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis

  2022cites this paper
• Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations.

  2022cites this paper
• Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index

  2022cites this paper
• Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience

  2022cites this paper
• Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series

  2022cites this paper
• Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme.

  2022cites this paper
• Assays of CFTR Function In Vitro, Ex Vivo and In Vivo

  2022cites this paper
• A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.

  2021cites this paper
• Self-Powered Point-of-Care Device for Galvanic Cell-Based Sample Concentration Measurement

  2021influential citation
• Recent Impact of Microfluidics on Skin Models for Perspiration Simulation

  2021cites this paper
• Analysis of national coverage of neonatal cystic fibrosis screening in Brazil from 2008 to 2017

  2021cites this paper
• Diagnostic tools and CFTR functional assays in cystic fibrosis: utility and availability in Switzerland.

  2021cites this paper
• Wearable Sweat Loss Measuring Devices: From the Role of Sweat Loss to Advanced Mechanisms and Designs

  2021cites this paper
• Rate normalization for sweat metabolomics biomarker discovery.

  2021cites this paper
• Colorimetric sensing of chloride in sweat based on fluorescence wavelength shift via halide exchange of CsPbBr3 perovskite nanocrystals

  2021cites this paper
• Cystic fibrosis

  2021cites this paper
• Clinical complications in children with false-negative results in cystic fibrosis newborn screening

  2021cites this paper
• Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable

  2021cites this paper
• Congenital Disorders of Intestinal Electrolyte Transport

  2021cites this paper
• Audit of sweat chloride testing reveals analytical errors

  2021cites this paper
• Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators

  2021cites this paper
• Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator‐related metabolic syndrome/CF screen‐positive, inconclusive diagnosis

  2021cites this paper
• Elevated sweat chloride test: is it always cystic fibrosis?

  2021cites this paper
• A 3D Printed Wearable Bioelectronic Patch for Multi‐Sensing and In Situ Sweat Electrolyte Monitoring

  2021cites this paper
• Annals of Otolaryngology and Rhinology The Connection between Cystic Fibrosis and Chronic Rhinosinusitis: A The Connection between Cystic Fibrosis and Chronic Rhinosinusitis: A Comprehensive Review

  2021cites this paper
• Cystic fibrosis in the kidney: new lessons from impaired renal HCO3− excretion

  2021cites this paper
• Antisense Oligonucleotide Therapy to Correct CFTR Function in People with Cystic Fibrosis

  2021cites this paper
• Wireless and battery-free platforms for collection of biosignals.

  2021cites this paper
• Lung stem cells and therapy for cystic fibrosis

  2021cites this paper
• CFTR-mediated monocyte-macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons

  2021cites this paper
• Epidermal sensors for monitoring skin physiology

  2020cites this paper
• TAS2R38 is a novel modifier gene in patients with cystic fibrosis

  2020cites this paper
• Processing Newborn Bloodspot Screening Results for CF

  2020cites this paper
• Evaluation of autonomic modulation of lung function and heart rate in children with cystic fibrosis

  2020cites this paper
• Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise

  2020cites this paper
• Comparison between two newborn screening strategies for cystic fibrosis in Argentina: IRT/IRT versus IRT/PAP

  2020cites this paper
• CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?

  2020cites this paper
• Topical Pilocarpine Formulation for diagnosis of Cystic Fibrosis.

  2020cites this paper
• Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion

  2020cites this paper
• Phenotypic and molecular characteristics of CF patients carrying the I1234V mutation.

  2020cites this paper
• Diagnosis of Cystic Fibrosis

  2020cites this paper
• Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis

  2020cites this paper